Again, another post pulled from Ed Silverman's Pharmalot blog. This one reminds us that the pharma market in Russia is every bit as active as those seen in India and China - perhaps more so - Russia is expecting 18% growth in 2010.
What's more? A large number of MNCs have stated they are considering plans or are underway in building new manufacturing capacity in Russia. These include AZ, GSK, Novartis, Novo Nordisk, Nycomed, Pfizer and Servier with about $1 B in investment under consideration. The Russian government plans to spend another $4 B on local industry players to boot.
Posted by Bruce Lehr June 22nd 2010.